Dis-Chem Pharmacies Limited (JSE: DCP)
South Africa
· Delayed Price · Currency is ZAR 3,535.00
-19.00 (-0.53%)
Sep 13, 2024, 10:18 AM SAST
Dis-Chem Pharmacies Income Statement
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '24 Feb 29, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2015 |
| Revenue | 36,283 | 36,283 | 32,664 | 30,407 | 26,278 | 23,984 | Upgrade
|
| Revenue Growth (YoY) | 11.08% | 11.08% | 7.42% | 15.71% | 9.56% | 11.97% | Upgrade
|
| Cost of Revenue | 28,067 | 28,067 | 25,076 | 23,576 | 20,442 | 18,429 | Upgrade
|
| Gross Profit | 8,217 | 8,217 | 7,587 | 6,830 | 5,836 | 5,556 | Upgrade
|
| Selling, General & Admin | 1,212 | 1,212 | 984.49 | 803.97 | 4,964 | 4,041 | Upgrade
|
| Other Operating Expenses | 5,201 | 5,201 | 4,837 | 4,467 | -1,173 | -369.84 | Upgrade
|
| Operating Expenses | 6,437 | 6,437 | 5,843 | 5,291 | 4,495 | 4,254 | Upgrade
|
| Operating Income | 1,779 | 1,779 | 1,744 | 1,539 | 1,341 | 1,301 | Upgrade
|
| Interest Expense | -466.23 | -466.23 | -370.45 | -324.85 | -344.58 | -402.05 | Upgrade
|
| Interest & Investment Income | 26.3 | 26.3 | 20.21 | 12.1 | 16.44 | 22.23 | Upgrade
|
| Earnings From Equity Investments | 45.27 | 45.27 | 22.78 | 1.19 | 3 | 0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.63 | -75.65 | -56.11 | Upgrade
|
| EBT Excluding Unusual Items | 1,385 | 1,385 | 1,417 | 1,227 | 940.49 | 865.3 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.46 | - | Upgrade
|
| Pretax Income | 1,385 | 1,385 | 1,417 | 1,227 | 940.94 | 868.84 | Upgrade
|
| Income Tax Expense | 364.09 | 364.09 | 389.18 | 337.12 | 253.29 | 240.65 | Upgrade
|
| Earnings From Continuing Operations | 1,020 | 1,020 | 1,028 | 890.1 | 687.65 | 628.2 | Upgrade
|
| Minority Interest in Earnings | -36.01 | -36.01 | -27.32 | -36.66 | -18.96 | -29.97 | Upgrade
|
| Net Income | 984.48 | 984.48 | 1,000 | 853.45 | 668.69 | 598.23 | Upgrade
|
| Net Income to Common | 984.48 | 984.48 | 1,000 | 853.45 | 668.69 | 598.23 | Upgrade
|
| Net Income Growth | -1.57% | -1.57% | 17.20% | 27.63% | 11.78% | -16.77% | Upgrade
|
| Shares Outstanding (Basic) | 858 | 858 | 860 | 860 | 860 | 860 | Upgrade
|
| Shares Outstanding (Diluted) | 858 | 858 | 860 | 860 | 860 | 860 | Upgrade
|
| Shares Change (YoY) | -0.26% | -0.26% | -0.01% | 0.08% | 0.00% | -0.04% | Upgrade
|
| EPS (Basic) | 1.15 | 1.15 | 1.16 | 0.99 | 0.78 | 0.70 | Upgrade
|
| EPS (Diluted) | 1.15 | 1.15 | 1.16 | 0.99 | 0.78 | 0.70 | Upgrade
|
| EPS Growth | -1.38% | -1.38% | 17.24% | 27.55% | 11.78% | -16.73% | Upgrade
|
| Free Cash Flow | 863.11 | 863.11 | 230 | 1,459 | 762.39 | 1,160 | Upgrade
|
| Free Cash Flow Per Share | 1.01 | 1.01 | 0.27 | 1.70 | 0.89 | 1.35 | Upgrade
|
| Dividend Per Share | 0.457 | 0.457 | 0.466 | 0.397 | 0.311 | 0.128 | Upgrade
|
| Dividend Growth | -1.79% | -1.79% | 17.34% | 27.60% | 143.11% | -62.56% | Upgrade
|
| Gross Margin | 22.65% | 22.65% | 23.23% | 22.46% | 22.21% | 23.16% | Upgrade
|
| Operating Margin | 4.90% | 4.90% | 5.34% | 5.06% | 5.10% | 5.42% | Upgrade
|
| Profit Margin | 2.71% | 2.71% | 3.06% | 2.81% | 2.54% | 2.49% | Upgrade
|
| Free Cash Flow Margin | 2.38% | 2.38% | 0.70% | 4.80% | 2.90% | 4.84% | Upgrade
|
| EBITDA | 2,165 | 2,165 | 2,079 | 1,790 | 1,580 | 1,492 | Upgrade
|
| EBITDA Margin | 5.97% | 5.97% | 6.36% | 5.89% | 6.01% | 6.22% | Upgrade
|
| D&A For EBITDA | 386.14 | 386.14 | 334.64 | 250.5 | 239.03 | 191.2 | Upgrade
|
| EBIT | 1,779 | 1,779 | 1,744 | 1,539 | 1,341 | 1,301 | Upgrade
|
| EBIT Margin | 4.90% | 4.90% | 5.34% | 5.06% | 5.10% | 5.42% | Upgrade
|
| Effective Tax Rate | 26.30% | 26.30% | 27.47% | 27.47% | 26.92% | 27.70% | Upgrade
|
| Advertising Expenses | 637.81 | 637.81 | 521.39 | 394.22 | 319.03 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.